L98.7 E65
Conditions
Interventions
Group 1: Stimulation group, undergoing stimulation for a duration of two weeks.
Group 2: Control group with a placebo device, which is worn identically to the active device for a duration of two weeks
Sponsors
Vanquish Innovation & Research
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients undergoing abdominoplasty at the BG Klinik, with the ability to understand the study and to sign consent form.
Exclusion criteria
Exclusion criteria: • Patients incapable of giving consent • patients with systemic disease (e.g., cancer, diabetes, etc.) • patients with implantable medical devices (e.g., cardiac pacemaker) • patients with suspected acute cardiac arrythmia • patients with epilepsy • patients taking regular medication impacting wound healing • smoking and other substance abuse • presence of soft tissue infections • BMI >35.0 and <17.5 kg/m2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjective and objective assessment of wound healing at 2 days, 7 days, 14 days, 4 weeks, and 3 months postoperatively, using O2C, TIVITA® Tissue System, UltraScan, and patient-reported questionnaires. | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of quality of life using patient-reported questionnaires. | — |
Countries
Germany
Contacts
Public ContactJohannes Tobias Thiel
BG Klinik Tübingen - Klinik für Hand-, Plastische, Rekonstruktive und Verbrennungschirurgie
Outcome results
None listed